Business
Colossal Biosciences Research and Development Investment Drug Development Costs Funding Genetic Engineering Firms Startups Gene Therapy Conservation Funding Clinical Development Drug Development
The therapy achieved up to 53% LDL cholesterol reduction without serious side effects, advancing toward Phase 2 trials in late 2025.
